Proton beam therapy for locally advanced lung cancer: A review.

about

The evolution of proton beam therapy: Current and future status.Calotropin regulates the apoptosis of non‑small cell cancer by regulating the cytotoxic T‑lymphocyte associated antigen 4‑mediated TGF‑β/ERK signaling pathway.

P2860

Q49333936-CD52D52B-763A-45D3-A5EB-BA3013002288 Q52605251-A45054AE-2026-45E4-A81A-12AF3170484C

P2860

Proton beam therapy for locally advanced lung cancer: A review.

Item

http://www.wikidata.org/entity/Q38258751

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Proton beam therapy for locally advanced lung cancer: A review.

@en

type

Item

label

Proton beam therapy for locally advanced lung cancer: A review.

@en

prefLabel

Proton beam therapy for locally advanced lung cancer: A review.

@en

P1476

Proton beam therapy for locally advanced lung cancer: A review.

@en

P2093

Aman Anand

http://www.w3.org/2001/XMLSchema#string

Jonathan B Ashman

http://www.w3.org/2001/XMLSchema#string

Sameer Keole

http://www.w3.org/2001/XMLSchema#string

Steven E Schild

http://www.w3.org/2001/XMLSchema#string

Sujay A Vora

http://www.w3.org/2001/XMLSchema#string

William G Rule

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2013

Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients.

Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lun

Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer.

Adaptive/nonadaptive proton radiation planning and outcomes in a phase II trial for locally advanced non-small cell lung cancer.

Treatment of non-small cell lung cancer, stage IIIB: ACCP evidence-based clinical practice guidelines (2nd edition).

The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly.

Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy.

The interplay of radiocurability and tolerance in the irradiation of human cancers.

Dosimetric rationale and early experience at UFPTI of thoracic proton therapy and chemotherapy in limited-stage small cell lung cancer.

P304

568-575

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5306/WJCO.V5.I4.568

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Martin Bues

Wei Liu

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266744124

http://www.w3.org/2001/XMLSchema#string

P698

25302161

http://www.w3.org/2001/XMLSchema#string

P932

4129522

http://www.w3.org/2001/XMLSchema#string

Proton beam therapy for locally advanced lung cancer: A review.

about

P2860

P2860

Proton beam therapy for locally advanced lung cancer: A review.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932